|
Diabetes, Vol 44, Issue 12 1399-1404, Copyright © 1995 by American Diabetes Association
Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia
AK Kumagai, YS Kang, RJ Boado and WM Pardridge
Department of Medicine, University of California at Los Angeles 90095-1682, USA.
An in vivo model of chronic hypoglycemia was used to investigate changes in
blood-brain barrier (BBB) glucose transport activity and changes in the
expression of GLUT1 mRNA and protein in brain microvasculature occurring as
an adaptive response to low circulating glucose levels. Chronic
hypoglycemia was induced in rats by constant infusion of insulin via
osmotic minipumps; control animals received infusions of saline. The
criterion for chronic hypoglycemia was an average blood glucose
concentration of < 2.3 mmol/l (42 mg/dl) after 5 days. The average blood
glucose concentration at the end of the experimental period in the rats
selected for study was 2.0 +/- 0.1 mmol/l (36 +/- 1 mg/dl) vs. 4.9 +/- 0.1
mmol/l (88 +/- 1 mg/dl) in the controls. Internal carotid artery perfusion
studies demonstrated an increase in the BBB permeability-surface area (PS)
product of 40% (P < 0.0005) in the chronically hypoglycemic animals as
compared with controls. Western blotting of solubilized isolated brain
capillaries demonstrated a 51% increase (P < 0.05) in immunoreactive BBB
GLUT1 in the chronically hypoglycemic rats, and Northern blotting of
whole-brain poly(A+) mRNA revealed a 50% increase in the GLUT1-to-actin
ratio in the insulin-treated group (P < 0.05). Northern blotting
analysis of microvessel-depleted total brain poly(A+) showed that the
increase in GLUT1 mRNA in the chronically hypoglycemic rats was restricted
to the BBB. The present study demonstrates increased expression of GLUT1
mRNA and protein at the BBB in chronic hypoglycemia and suggests that this
increase is responsible for the compensatory increase in BBB glucose
transport activity that occurs with chronically low circulating blood
glucose levels.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Chan, H. Cheng, R. Herzog, D. Czyzyk, W. Zhu, A. Wang, R. J. McCrimmon, M. R. Seashore, and R. S. Sherwin
Increased GABAergic Tone in the Ventromedial Hypothalamus Contributes to Suppression of Counterregulatory Reponses After Antecedent Hypoglycemia
Diabetes,
May 1, 2008;
57(5):
1363 - 1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. McCrimmon, X. Fan, H. Cheng, E. McNay, O. Chan, M. Shaw, Y. Ding, W. Zhu, and R. S. Sherwin
Activation of AMP-Activated Protein Kinase Within the Ventromedial Hypothalamus Amplifies Counterregulatory Hormone Responses in Rats With Defective Counterregulation
Diabetes,
June 1, 2006;
55(6):
1755 - 1760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Diabetes,
December 1, 2005;
54(12):
3592 - 3601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. McNay and R. S. Sherwin
Effect of Recurrent Hypoglycemia on Spatial Cognition and Cognitive Metabolism in Normal and Diabetic Rats
Diabetes,
February 1, 2004;
53(2):
418 - 425.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. M. Cheng, B. Kelley, J. Wang, D. Strauss, D. A. Eagles, and C. A. Bondy
A Ketogenic Diet Increases Brain Insulin-Like Growth Factor Receptor and Glucose Transporter Gene Expression
Endocrinology,
June 1, 2003;
144(6):
2676 - 2682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Mann, D. L. Yudilevich, and L. Sobrevia
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Physiol Rev,
January 1, 2003;
83(1):
183 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. de Galan, C. J. Tack, J. W. Lenders, J. W. Pasman, L. D. Elving, F. G. Russel, J. A. Lutterman, and P. Smits
Theophylline Improves Hypoglycemia Unawareness in Type 1 Diabetes
Diabetes,
March 1, 2002;
51(3):
790 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dantz, J. Bewersdorf, B. Fruehwald-Schultes, W. Kern, W. Jelkmann, J. Born, H. L. Fehm, and A. Peters
Vascular Endothelial Growth Factor: A Novel Endocrine Defensive Response to Hypoglycemia
J. Clin. Endocrinol. Metab.,
February 1, 2002;
87(2):
835 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cranston, L. J. Reed, P. K. Marsden, and S. A. Amiel
Changes in Regional Brain 18F-Fluorodeoxyglucose Uptake at Hypoglycemia in Type 1 Diabetic Men Associated With Hypoglycemia Unawareness and Counter-Regulatory Failure
Diabetes,
October 1, 2001;
50(10):
2329 - 2366.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer
Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia
Diabetes,
August 1, 2001;
50(8):
1911 - 1917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gabriely, R. Wozniak, M. Hawkins, and H. Shamoon
Troglitazone Amplifies Counterregulatory Responses to Hypoglycemia in Nondiabetic Subjects
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
521 - 528.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. E. Kim, S. H. Park, S. K. Kim, H. W. Nam, Y. S. Lee, J- K. Chung, and J. K. Roh
Hypoglycemia-induced cerebellar dysfunction and quantitative positron emission tomography study
Neurology,
August 8, 2000;
55(3):
418 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sone, B. K. Deo, and A. K. Kumagai
Enhancement of Glucose Transport by Vascular Endothelial Growth Factor in Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
June 1, 2000;
41(7):
1876 - 1884.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Fruehwald-Schultes, W. Kern, E. Deininger, P. Wellhoener, W. Kerner, J. Born, H. L. Fehm, and A. Peters
Protective Effect of Insulin against Hypoglycemia-Associated Counterregulatory Failure
J. Clin. Endocrinol. Metab.,
May 1, 1999;
84(5):
1551 - 1557.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. W. Jones, W. P. Borg, M. A. Borg, S. D. Boulware, G. McCarthy, D. Silver, W. V. Tamborlane, and R. S. Sherwin
Resistance to Neuroglycopenia: An Adaptative Response during Intensive Insulin Treatment of Diabetes
J. Clin. Endocrinol. Metab.,
June 1, 1997;
82(6):
1713 - 1718.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|